Roche Nabs FDA Approval For First-Of-Its-Kind Malaria Test

The US FDA has approved Roche’s cobas Malaria test, which screens blood donors in the US for malaria. The cobas is the first such diagnostic to win agency approval.

Malaria Mosquitoe
• Source: Shutterstock

The Food and Drug Administration has approved a molecular test from Roche, which allows health care professionals to screen for the disease in blood, organ, and tissue donors, and thus, reduce the spread of malaria.

The cobas test provides “a highly sensitive and specific solution” to ensure that infected blood units are removed from the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation